Cryo Cell International (CCEL) Cost of Revenue (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Cost of Revenue data on file, last reported at $1.7 million in Q1 2026.

• Quarterly Cost of Revenue fell 16.53% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $7.0 million (down 9.31% YoY) and the FY2025 annual result came in at $7.4 million, down 7.19% from the prior year.
• Cost of Revenue eased to $1.7 million in Q1 2026 per CCEL's latest filing, from $1.7 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.3 million in Q3 2022 and bottomed at $1.6 million in Q4 2024.
• The 5-year median for Cost of Revenue is $2.1 million (2024), against an average of $2.0 million.
• The widest annual swing landed in 2024, when Cost of Revenue fell 19.13%; it then climbed 5.95% in 2025.
• Tracing CCEL's Cost of Revenue over 5 years: stood at $2.1 million in 2022, then slipped by 5.38% to $2.0 million in 2023, then slipped by 19.13% to $1.6 million in 2024, then grew by 5.95% to $1.7 million in 2025, then dropped by 4.48% to $1.7 million in 2026.
• Per Business Quant, the three latest CCEL Cost of Revenue figures stand at $1.7 million (Q1 2026), $1.7 million (Q4 2025), and $1.8 million (Q3 2025).

Peer Comparison